Results 261 to 270 of about 491,007 (324)

The smear layer comparison in each group using hoc Dunn’s test corrected by Bonferroni.

Maryam Saber Mahdi (22403493), Ranjdar Mahmood Talabani (22403496)   +1 more
openalex   +1 more source

Next‐generation proteomics improves lung cancer risk prediction

Molecular Oncology, EarlyView.
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj, Clara Frick, Ben Schöttker, Bernd Holleczek, Hermann Brenner   +4 more
wiley   +1 more source

HPV Self-Sampling Promotion Among African American (AA) and Sub-Saharan African (SAI) Immigrant Women: Adaptation and Usability Testing. [PDF]

Int J Environ Res Public Health
Adegboyega A, Mudd-Martin G, Schoenberg NE, Dignan M.   +3 more
europepmc   +1 more source

Comparison with SOTA: After training the models using three different approaches—(1) applying CLAHE (), (2) applying Ben Graham’s preprocessing technique (♦), and (3) our proposed () pipeline without sophisticated preprocessing—we evaluated them on the actual test sets of the APTOS2019 and Messidor-2 datasets.

Zarin Akter (22794652), Jawad Ibn Ahad (22794655), Md. Mutasim Farhan (22794658), Riasat Khan (20135822)   +3 more
openalex   +1 more source

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

Molecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak, Karolina Pytlak, Sandra Jaworowska, Bogusz Kulawiak, Piotr Bednarczyk   +4 more
wiley   +1 more source

Empowering WHISE women: usability testing of a mobile application to enhance blood pressure control. [PDF]

Mhealth
Jones LM, Monroe KE, Tripathi P, Bashshur MJ, Kavalakatt J, Tarrance K, Mitchell J, Hawkins J.   +7 more
europepmc   +1 more source

Results from heterogeneity test using difference-in-means estimator.

Vishalie Shah (7301909), Noemi Kreif (8414208)   +1 more
openalex   +1 more source

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

Molecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute, Júlia Huguet‐Pradell, Jordi Abril‐Fornaguera, Albert Gris‐Oliver, Alex Rialdi, Elisa Fernández‐Martínez, Carla Montironi, Vanessa Del Pozo, Peter Houghton, Laura Zanatto, Agavni Mesropian, Ieva Keraite, Swan Thung, Carolina Armengol, Pau Sancho‐Bru, Ernesto Guccione, Roser Pinyol, Josep M. Llovet   +17 more
wiley   +1 more source

Development and usability testing of an online platform for provider training and implementation of cognitive-behavioral therapy guided self-help for eating disorders. [PDF]

BMC Digit Health
D'Adamo L, Laboe AA, Goldberg J, Howe CP, Steinhoff MF, DePietro B, Firebaugh ML, Cooper Z, Wilfley DE, Fitzsimmons-Craft EE.   +9 more
europepmc   +1 more source